Inhibition of human platelet aggregation by a dibenzazepine compound (GP 44296) and by N-(2,6-dichlorophenyl)-o-aminophenylacetic acid (GP 45840).
D000244:Adenosine Diphosphate / Q000037:antagonists & inhibitors; D001792:Blood Platelets / Q000187:drug effects*; D002449:Cell Aggregation / Q000187:drug effects*; D055598:Chemical Phenomena; D002621:Chemistry; D003094:Collagen / Q000037:antagonists & inhibitors; D003720:Densitometry; D003984:Dibenzazepines / Q000494:pharmacology*; D006801:Humans; D010648:Phenylacetates / Q000494:pharmacology*; D010973:Platelet Adhesiveness / Q000187:drug effects; D011720:Pyrazoles / Q000494:pharmacology
D003984:Dibenzazepines; D010648:Phenylacetates; D011720:Pyrazoles; D000244:Adenosine Diphosphate; D003094:Collagen